Report : North America Autotransfusion Devices Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Products and Accessories), Application (Cardiac Surgeries, Orthopedic Surgeries, Organ Transplantation, Trauma Procedures, and Others), and End User (Hospitals, Specialty Clinics, and Ambulatory Surgery Centers)Â
Accessories Segment to Dominate North America Autotransfusion Devices Market during 2019–2028
According to a new market research study on “North America Autotransfusion Devices Market to 2028 – COVID-19 Impact and Regional Analysis and Forecast by Type, Application, and End User,” is expected to reach US$ 448.50 million by 2028 from US$ 328.30 million in 2021. The market is estimated to grow at a CAGR of 4.6% from 2021 to 2028. Rise in transplants is the major factor driving the growth of the North America autotransfusion devices market. However, product recalls may hinder the growth of North America autotransfusion devices market. The report provides trends prevailing in the North America autotransfusion devices market along with the drivers and restraints pertaining to the market growth.
The North America autotransfusion devices market is segmented into type, application, end user, and country. The North America autotransfusion devices market, by type, is segmented into products and accessories. In 2021, the accessories segment held the largest share North America autotransfusion devices market. The products is further sub-segmented into intraoperative autotransfusion systems, postoperative autotransfusion systems, and dual-mode autotransfusion systems. In 2021, the intraoperative autotransfusion systems segment held the largest share North America autotransfusion devices market. The North America autotransfusion devices market, by application, is segmented into cardiac surgeries, orthopedic surgeries, organ transplantation, trauma procedures, and others. The cardiac surgeries segment held the largest share of the market in 2021. Based on end user, the North America autotransfusion devices market is segmented hospitals, specialty clinics, and ambulatory surgical centers. The hospitals segment held the largest share of the market in 2021. Similarly, based on country, the North America autotransfusion devices market is segmented into the US, Canada, and Mexico. The US contributed a substantial share in 2021.
BD, Braile Biomedica, Fresenius SE & Co. KGaA, Haemonetics Corporation, LivaNova PLC, Medtronic, Redax S.p.A., SARSTEDT AG and Co. KG, Teleflex Incorporated, and Zimmer Biomet are among the leading companies in the North America autotransfusion devices market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in 2018, Medtronic received FDA approval for its advanced autoLog IQ Autotransfusion System. The newly approved system offers postoperative autotransfusion mechanism in cardiovascular, orthopedics, neurology, and other types of surgeries.
Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@businessmarketinsights.com